Merck's Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study results - MarketWatch https://t.co/DqJaA0UPZ1
— IDRO (@IDROOhio) April 26, 2019
from Twitter https://twitter.com/IDROOhio
April 26, 2019 at 06:35AM
No comments:
Post a Comment